Health Policy Manag.  2024 Jun;34(2):178-184. 10.4332/KJHPA.2024.34.2.178.

Changes in the Behavior of Healthcare Organizations Following the Introduction of Drug Utilization Review Evaluation Indicators in the Healthcare Quality Evaluation Grant Initiative

• Kim HJ
• Yoo KB
• Won YJ
• Jang HS
• Lee KS

• KMID: 2562575
• DOI: http://doi.org/10.4332/KJHPA.2024.34.2.178

Abstract

Background
This study aimed to determine the effectiveness of drug utilization review (DUR) evaluation indicators on safe drug use by comparing the changes in DUR inspection rates and drug duplication prescription prevention rates between the pre- and post-implementation of the DUR evaluation indicators of the Healthcare Quality Evaluation Grant Initiative.
Methods
This study used DUR data from the Health Insurance Review and Assessment Service in 2018 (pre-implementation) and the evaluation results of the Healthcare Quality Evaluation Grant Initiative in 2023 (post-implementation). The dependent variables were the DUR evaluation indicators, including DUR inspection rate and drug duplicate prescription prevention rate. The independent variable was the implementation of the DUR evaluation indicators, and the control variables included medical institution characteristics such as type, establishment classification, location, DUR billing software company, and number of beds.
Results
The results of the analysis of the difference in the prevention rate of drug duplicate prescriptions between the pre- and postimplementation of the DUR evaluation indicators of the Healthcare Quality Evaluation Grant Initiative showed that the prevention rate of drug duplicate prescriptions increased statistically significantly after the implementation of the DUR evaluation indicators.
Conclusion
The policy implications of this study are as follows: First, ongoing evaluation of DUR systems is needed. Second, it is necessary to establish a collaborative partnership between healthcare organizations that utilize DUR system information and the organizations that manage it.

Keyword

Drug utilization review; Healthcare Quality Evaluation Grant Initiative; DUR inspection rate; Drug duplicate prescription prevention rate